{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:28:44Z","timestamp":1785522524165,"version":"3.56.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40744-026-00863-0","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:05:22Z","timestamp":1781607922000},"page":"997-1053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinically Amyopathic Dermatomyositis: Epidemiology, Clinical Presentation, Pathophysiology, Treatment, and Prognosis: A Systematic Review"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-7959","authenticated-orcid":false,"given":"Jucier","family":"Gon\u00e7alves J\u00fanior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6049-0697","authenticated-orcid":false,"given":"Jamily Izabel Alves","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3682-4517","authenticated-orcid":false,"given":"Samuel Katsuyuki","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"4","key":"863_CR1","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.chest.2020.06.001","volume":"158","author":"MC Baker","year":"2020","unstructured":"Baker MC, Chung L, Fiorentino DF. A mortality risk score model for clinically amyopathic dermatomyositis-associated interstitial lung disease: will it have the necessary \u201cFLAIR\u201d to improve clinical outcomes? Chest. 2020;158(4):1307\u20139.","journal-title":"Chest"},{"issue":"2","key":"863_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11926-023-01126-5","volume":"26","author":"J Gon\u00e7alves J\u00fanior","year":"2024","unstructured":"Gon\u00e7alves J\u00fanior J, Shinjo SK. Calcinosis in juvenile dermatomyositis-epidemiology, pathogenesis, clinical features, and treatment: a systematic review. Curr Rheumatol Rep. 2024;26(2):53\u201368.","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"863_CR3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/ph18091293","volume":"18","author":"J Gon\u00e7alves J\u00fanior","year":"2025","unstructured":"Gon\u00e7alves J\u00fanior J, Santos JIA, Shinjo SK. Is hydroxychloroquine useful for the treatment of cutaneous manifestations of idiopathic inflammatory myopathies? A systematic review. Pharmaceuticals. 2025;18(9):1293.","journal-title":"Pharmaceuticals"},{"issue":"151959","key":"863_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.151959","volume":"53","author":"M McPherson","year":"2022","unstructured":"McPherson M, Economidou S, Liampas A, Zis P, Parperis K. Management of MDA-5 antibody-positive clinically amyopathic dermatomyositis-associated interstitial lung disease: a systematic review. Semin Arthritis Rheum. 2022;53(151959):151959.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"863_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMc1900045","volume":"381","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang X, Ye S. Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease. N Engl J Med. 2019;381(3):291\u20133.","journal-title":"N Engl J Med"},{"issue":"11","key":"863_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-237250","volume":"13","author":"Z Miyake","year":"2020","unstructured":"Miyake Z, Ishii A, Okiyama N, Tamaoka A. Amyopathic dermatomyositis combined with peripheral neuropathy. BMJ Case Rep. 2020;13(11):e237250.","journal-title":"BMJ Case Rep"},{"issue":"4","key":"863_CR7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","volume":"158","author":"X Lian","year":"2020","unstructured":"Lian X, Zou J, Guo Q, Chen S, Lu L, Wang R, et al. Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model. Chest. 2020;158(4):1535\u201345.","journal-title":"Chest"},{"issue":"6","key":"863_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1332","volume":"12","author":"W Wang","year":"2024","unstructured":"Wang W, Sun X, Xu Y, Tan W, Liu Y, Zhou J. Prognostic analysis of MDA5-associated clinically amyopathic dermatomyositis with interstitial lung disease. Immun Inflamm Dis. 2024;12(6):e1332.","journal-title":"Immun Inflamm Dis"},{"issue":"1","key":"863_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Bendewald","year":"2010","unstructured":"Bendewald MJ, Wetter DA, Li X, Davis MDP. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted county, Minnesota. Arch Dermatol. 2010;146(1):26.","journal-title":"Arch Dermatol"},{"key":"863_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1237209","volume":"14","author":"Q Ji","year":"2023","unstructured":"Ji Q, Pan W, Zhang D, Hou Y, Wang Z. Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study. Front Immunol. 2023;14:1237209.","journal-title":"Front Immunol"},{"issue":"5","key":"863_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00296-012-2545-7","volume":"33","author":"Y Sun","year":"2013","unstructured":"Sun Y, Liu Y, Yan B, Shi G. Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients. Rheumatol Int. 2013;33(5):1295\u2013302.","journal-title":"Rheumatol Int"},{"issue":"9","key":"863_CR12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.rmed.2015.07.004","volume":"109","author":"T Takada","year":"2015","unstructured":"Takada T, Aoki A, Asakawa K, Sakagami T, Moriyama H, Narita I, et al. Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody-positive amyopathic dermatomyositis. Respir Med. 2015;109(9):1174\u201380.","journal-title":"Respir Med"},{"issue":"1","key":"863_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10067-015-3080-1","volume":"35","author":"J Zou","year":"2016","unstructured":"Zou J, Chen J, Yan Q, Guo Q, Bao C. Serum IL8 and mRNA level of CD11b in circulating neutrophils are increased in clinically amyopathic dermatomyositis with active interstitial lung disease. Clin Rheumatol. 2016;35(1):117\u201325.","journal-title":"Clin Rheumatol"},{"key":"863_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep33226","volume":"6","author":"T Li","year":"2016","unstructured":"Li T, Guo L, Chen Z, Gu L, Sun F, Tan X, et al. Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis. Sci Rep. 2016;6:33226.","journal-title":"Sci Rep"},{"issue":"1","key":"863_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12890-017-0479-2","volume":"17","author":"H Okabayashi","year":"2017","unstructured":"Okabayashi H, Ichiyasu H, Hirooka S, Akaike K, Kojima K, Jodai T, et al. Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias. BMC Pulm Med. 2017;17(1):134.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"863_CR16","first-page":"803","volume":"37","author":"W Huang","year":"2019","unstructured":"Huang W, Ren F, Wang Q, Luo L, Zhou J, Huang D, et al. Clinical features of thirty-two patients with anti-melanoma differentiation-associated gene 5 antibodies. Clin Exp Rheumatol. 2019;37(5):803\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"863_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.783416","volume":"8","author":"K Tang","year":"2021","unstructured":"Tang K, Zhang H, Jin H. Clinical characteristics and management of patients with clinical amyopathic dermatomyositis: a retrospective study of 64 patients at a tertiary dermatology department. Front Med (Lausanne). 2021;8:783416.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"863_CR18","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1093\/rheumatology\/keac030","volume":"61","author":"MPM Hensgens","year":"2022","unstructured":"Hensgens MPM, Delemarre EM, Drylewicz J, Voortman M, Krol RM, Dalm VASH, et al. Clinical features and immune-related protein patterns of anti-MDA5-positive clinically amyopathic dermatomyositis Dutch patients. Rheumatology (Oxford). 2022;61(10):4087\u201396.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"863_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10238-024-01300-8","volume":"24","author":"S Hirsch","year":"2024","unstructured":"Hirsch S, P\u00f6hler GH, Seeliger B, Prasse A, Witte T, Thiele T. Treatment strategies in MDA5-positive clinically amyopathic dermatomyositis: a single-center retrospective analysis. Clin Exp Med. 2024;24(1):37.","journal-title":"Clin Exp Med"},{"issue":"5","key":"863_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s100670200104","volume":"21","author":"C-S Lee","year":"2002","unstructured":"Lee C-S, Chen T-L, Tzen C-Y, Lin F-J, Peng M-J, Wu C-L, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol. 2002;21(5):391\u20136.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"863_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0001-7310(05)75057-2","volume":"96","author":"LC P\u00e9rez-P\u00e9rez","year":"2005","unstructured":"P\u00e9rez-P\u00e9rez LC, Su\u00e1rez-Amor \u00d3, S\u00e1nchez-Aguilar D, Ginarte M, Pereiro M, Toribio J. Dermatomiositis cl\u00ednicamente amiop\u00e1tica: presentaci\u00f3n de tres casos. Actas Dermosifiliogr. 2005;96(5):295\u20138.","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"863_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s10067-005-0147-4","volume":"26","author":"E Miyazaki","year":"2007","unstructured":"Miyazaki E, Ando M, Muramatsu T, Fukami T, Matsuno O, Nureki S-I, et al. Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis. Clin Rheumatol. 2007;26(3):436\u20139.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"863_CR23","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s10067-015-2928-8","volume":"35","author":"G Bornstein","year":"2016","unstructured":"Bornstein G, Lidar M, Langevitz P, Grossman C. Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review. Clin Rheumatol. 2016;35(8):2125\u201330.","journal-title":"Clin Rheumatol"},{"issue":"101299","key":"863_CR24","volume":"31","author":"P Intapiboon","year":"2020","unstructured":"Intapiboon P, Siripaitoon B. Erythematous auricular papules in the fatal cases of anti-MDA5 antibody-positive interstitial lung disease. Respir Med Case Rep. 2020;31(101299):101299.","journal-title":"Respir Med Case Rep"},{"issue":"1","key":"863_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.701","volume":"9","author":"P Kaenmuang","year":"2021","unstructured":"Kaenmuang P, Navasakulpong A. Clinical characteristics of anti-MDA5 antibody-positive interstitial lung disease. Respirol Case Rep. 2021;9(1):e00701.","journal-title":"Respirol Case Rep"},{"issue":"23","key":"863_CR26","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.12998\/wjcc.v11.i23.5580","volume":"11","author":"W-Z Ye","year":"2023","unstructured":"Ye W-Z, Peng S-S, Hu Y-H, Fang M-P, Xiao Y. Anti-melanoma differentiation-associated gene 5 and anti-Ro52 antibody-dual-positive dermatomyositis accompanied by rapidly lung disease: three case reports. World J Clin Cases. 2023;11(23):5580\u20138.","journal-title":"World J Clin Cases"},{"issue":"2","key":"863_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5387\/fms.48.103","volume":"48","author":"K Sugisaki","year":"2002","unstructured":"Sugisaki K, Takeda I, Iwadate H, Kanno T, Nishimaki T, Kasukawa R. Prevention of progression of interstitial lung lesions by early combination therapy with corticosteroids and cyclosporine\/cyclophosphamide in two patients with amyopathic dermatomyositis. Fukushima J Med Sci. 2002;48(2):103\u201310.","journal-title":"Fukushima J Med Sci"},{"issue":"9","key":"863_CR28","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2169\/internalmedicine.43.838","volume":"43","author":"N Sakamoto","year":"2004","unstructured":"Sakamoto N, Mukae H, Fujii T, Yoshioka S, Kakugawa T, Yamaguchi H, et al. Nonspecific interstitial pneumonia with poor prognosis associated with amyopathic dermatomyositis. Intern Med. 2004;43(9):838\u201342.","journal-title":"Intern Med"},{"issue":"3","key":"863_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0001-7310(04)76795-2","volume":"95","author":"M Rodr\u00edguez-V\u00e1zquez","year":"2004","unstructured":"Rodr\u00edguez-V\u00e1zquez M, Romero-Aguilera G, Garc\u00eda-Arpa M, Mart\u00edn-D\u00e1vila F, Cortina de la Calle P. Paniculitis asociada a dermatomiositis amiop\u00e1tica. Actas Dermosifiliogr. 2004;95(3):189\u201392.","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"863_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0885066605275391","volume":"20","author":"T Yokoyama","year":"2005","unstructured":"Yokoyama T, Sakamoto T, Shida N, Kinoshita M, Kunou Y, Karukaya R, et al. Fatal rapidly progressive interstitial pneumonitis associated with amyopathic dermatomyositis and CD8 T lymphocytes. J Intensive Care Med. 2005;20(3):160\u20133.","journal-title":"J Intensive Care Med"},{"issue":"3","key":"863_CR31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jbspin.2005.05.004","volume":"73","author":"B Saoud","year":"2006","unstructured":"Saoud B, Allali F, Hassouni NH. Amyopathic dermatomyositis. Jt Bone Spine. 2006;73(3):318\u201320.","journal-title":"Jt Bone Spine"},{"issue":"2","key":"863_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1590\/S0365-05962006000200011","volume":"81","author":"L Galr\u00e3o","year":"2006","unstructured":"Galr\u00e3o L, Reale J, Lima I, Santiago M. Efic\u00e1cia da dapsona em dois casos de dermatomiosite amiop\u00e1tica. An Bras Dermatol. 2006;81(2):181\u20132.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"863_CR33","first-page":"189","volume":"35","author":"MCW Rey","year":"2007","unstructured":"Rey MCW, Dazzi PB, Rockenbach M, Bernardes SC, Furian R, Libis AS, et al. Papular mucinosis: uncommon presentation of amyopathic dermatomyositis. Med Cutan Iber Lat Am. 2007;35(4):189\u201392.","journal-title":"Med Cutan Iber Lat Am"},{"issue":"8","key":"863_CR34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2169\/internalmedicine.47.0639","volume":"47","author":"T Kakugawa","year":"2008","unstructured":"Kakugawa T, Mukae H, Saito M, Ishii K, Ishimoto H, Sakamoto N, et al. Rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis successfully treated with polymyxin B-immobilized fiber column hemoperfusion. Intern Med. 2008;47(8):785\u201390.","journal-title":"Intern Med"},{"issue":"4","key":"863_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10067-009-1358-x","volume":"29","author":"M Ando","year":"2010","unstructured":"Ando M, Miyazaki E, Yamasue M, Sadamura Y, Ishii T, Takenaka R, et al. Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine. Clin Rheumatol. 2010;29(4):443\u20135.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"863_CR36","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10165-011-0558-9","volume":"22","author":"S Sato","year":"2012","unstructured":"Sato S, Kuwana M, Fujita T, Suzuki Y. Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140\/MDA5 autoantibodies. Mod Rheumatol. 2012;22(4):625\u20139.","journal-title":"Mod Rheumatol"},{"key":"863_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/750275","volume":"2013","author":"O Sasaki","year":"2013","unstructured":"Sasaki O, Dohi M, Harada H, Imamura M, Tsuchida Y, Yamaguchi K, et al. A case of polymyxin b-immobilized fiber column treatment for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis. Case Rep Med. 2013;2013:750275.","journal-title":"Case Rep Med"},{"issue":"14","key":"863_CR38","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2169\/internalmedicine.53.0738","volume":"53","author":"Y Iijima","year":"2014","unstructured":"Iijima Y, Furusawa H, Tateishi T, Tsuchiya K, Fujie T, Tamaoka M, et al. Amyopathic dermatomyositis complicated with eosinophilic pneumonia. Intern Med. 2014;53(14):1539\u201344.","journal-title":"Intern Med"},{"issue":"21","key":"863_CR39","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.2169\/internalmedicine.53.2769","volume":"53","author":"K Tamai","year":"2014","unstructured":"Tamai K, Tachikawa R, Otsuka K, Ueda H, Hosono Y, Tomii K. Early pulmonary involvement of anti-CADM-140 autoantibody-positive rapidly progressive interstitial lung disease preceding typical cutaneous symptoms. Intern Med. 2014;53(21):2515\u20139.","journal-title":"Intern Med"},{"key":"863_CR40","doi-asserted-by":"publisher","unstructured":"Ugan Y, Sahin M, Dogru A, Bayram D, Ceyhan AM, Tunc SE. A case of amyopathic dermatomyositis associated with interstitial pulmonary disease. Clin Ter. 2015;166(6):253\u20135. https:\/\/doi.org\/10.7417\/CT.2015.1897.","DOI":"10.7417\/CT.2015.1897"},{"issue":"5","key":"863_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/jamadermatol.2014.5070","volume":"151","author":"MG Kirchhof","year":"2015","unstructured":"Kirchhof MG, Dutz JP. Amyopathic dermatomyositis-related thrombophilia. JAMA Dermatol. 2015;151(5):559\u201361.","journal-title":"JAMA Dermatol"},{"key":"863_CR42","volume":"2015","author":"A G\u00fcr\u00fcn Kaya","year":"2015","unstructured":"G\u00fcr\u00fcn Kaya A, \u00c7ileda\u011f A, K\u00fc\u00e7\u00fck\u015fahin O, \u00d6zdemir Kumbasar \u00d6, Atasoy \u00c7. A case of amyopathic dermatomyositis with pneumomediastinum and subcutaneous emphysema. Case Rep Rheumatol. 2015;2015:813902.","journal-title":"Case Rep Rheumatol"},{"issue":"2","key":"863_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5152\/eurjrheum.2015.0076","volume":"2","author":"K Hamada-Ode","year":"2015","unstructured":"Hamada-Ode K, Taniguchi Y, Kimata T, Kawaguchi Y, Shimamura Y, Kuwana M, et al. High-dose intravenous immunoglobulin therapy for rapidly progressive interstitial pneumonitis accompanied by anti-melanoma differentiation-associated gene 5 antibody-positive amyopathic dermatomyositis. Eur J Rheumatol. 2015;2(2):83\u20135.","journal-title":"Eur J Rheumatol"},{"issue":"12","key":"863_CR44","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2169\/internalmedicine.55.6055","volume":"55","author":"N Yoshida","year":"2016","unstructured":"Yoshida N, Kaieda S, Tomozoe K, Tajiri M, Wakasugi D, Okamoto M, et al. An autopsy case of anti-melanoma differentiation-associated gene-5 antibody-positive clinical amyopathic dermatomyositis complicated by rapidly progressive interstitial lung disease. Intern Med. 2016;55(12):1653\u20139.","journal-title":"Intern Med"},{"key":"863_CR45","first-page":"5","volume":"19","author":"A Suzuki","year":"2016","unstructured":"Suzuki A, Kondoh Y, Taniguchi H, Tabata K, Kimura T, Kataoka K, et al. Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis. Respir Med Case Rep. 2016;19:5\u20138.","journal-title":"Respir Med Case Rep"},{"key":"863_CR46","doi-asserted-by":"publisher","unstructured":"Lim JU, Kang HS, Kim YH, Kim T-J. Amyopathic dermatomyositis associated with histopathological findings of organizing pneumonia and pulmonary vasculitis. Balkan Med J. 2017;34(4):374\u20137. https:\/\/doi.org\/10.4274\/balkanmedj.2016.1061.","DOI":"10.4274\/balkanmedj.2016.1061"},{"issue":"3","key":"863_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2169\/internalmedicine.56.6856","volume":"56","author":"Y Sato","year":"2017","unstructured":"Sato Y, Otsuka K, Tamai K, Ono Y, Hamaguchi Y, Tomii K. An atypical clinical course of anti-MDA5 antibody-positive interstitial lung disease in a patient with three deteriorations in 9 years. Intern Med. 2017;56(3):341\u20136.","journal-title":"Intern Med"},{"issue":"2","key":"863_CR48","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jdcr.2017.01.013","volume":"3","author":"A Sharma","year":"2017","unstructured":"Sharma A, Hudson M, Watters K, Billick R, Fallavolita S, Netchiporouk E. Rapidly progressive melanoma differentiation-associated protein 5-positive amyopathic dermatomyositis in an HIV-positive patient. JAAD Case Rep. 2017;3(2):158\u201361.","journal-title":"JAAD Case Rep"},{"key":"863_CR49","doi-asserted-by":"publisher","unstructured":"Parperis K, Kiyani A. Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody. BMJ Case Rep. 2018;2018:bcr2017222060. https:\/\/doi.org\/10.1136\/bcr-2017-222060.","DOI":"10.1136\/bcr-2017-222060"},{"issue":"1","key":"863_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/idoj.IDOJ_72_17","volume":"9","author":"A Agull\u00f3","year":"2018","unstructured":"Agull\u00f3 A, Hinds B, Larrea M, Yanguas I. Livedo racemosa, reticulated ulcerations, panniculitis and violaceous plaques in a 46-year-old woman. Indian Dermatol Online J. 2018;9(1):47\u20139.","journal-title":"Indian Dermatol Online J"},{"key":"863_CR51","first-page":"189","volume":"25","author":"E Tsumiyama","year":"2018","unstructured":"Tsumiyama E, Yamakawa H, Sato S, Oba T, Nishizawa T, Kawabe R, et al. A case of anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease complicated with tracheobronchial ulcers. Respir Med Case Rep. 2018;25:189\u201391.","journal-title":"Respir Med Case Rep"},{"issue":"13","key":"863_CR52","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.2169\/internalmedicine.0297-17","volume":"57","author":"M Yagishita","year":"2018","unstructured":"Yagishita M, Kondo Y, Terasaki T, Terasaki M, Shimizu M, Honda F, et al. Clinically amyopathic dermatomyositis with interstitial pneumonia that was successfully treated with plasma exchange. Intern Med. 2018;57(13):1935\u20138.","journal-title":"Intern Med"},{"issue":"22","key":"863_CR53","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010946","volume":"97","author":"J Huang","year":"2018","unstructured":"Huang J, Liu C, Zhu R, Su Y, Lin J, Lu J, et al. Combined usage of extracorporeal membrane oxygenation and double filtration plasmapheresis in amyopathic dermatomyositis patient with severe interstitial lung disease: a case report. Medicine (Baltimore). 2018;97(22):e10946.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"863_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13104-018-3146-7","volume":"11","author":"K Yamada","year":"2018","unstructured":"Yamada K, Asai K, Okamoto A, Watanabe T, Kanazawa H, Ohata M, et al. Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report. BMC Res Notes. 2018;11(1):34.","journal-title":"BMC Res Notes"},{"issue":"5","key":"863_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.326","volume":"6","author":"Y Aono","year":"2018","unstructured":"Aono Y, Eifuku T, Uto T, Sato J, Imokawa S, Suda T. Non-specific interstitial pneumonia associated with clinically amyopathic dermatomyositis showing \u201ccrazy paving\u201d appearance on thin-section lung CT. Respirol Case Rep. 2018;6(5):e00326.","journal-title":"Respirol Case Rep"},{"issue":"1","key":"863_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1590\/abd1806-4841.20186597","volume":"93","author":"PdeO Azevedo","year":"2018","unstructured":"Azevedo PdeO, Castellen NR, Salai AF, Barbosa FS, Alves CAXdeM, Pinto CAL. Panniculitis associated with amyopathic dermatomyositis. An Bras Dermatol. 2018;93(1):119\u201321.","journal-title":"An Bras Dermatol"},{"issue":"3","key":"863_CR57","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2169\/internalmedicine.8335-16","volume":"57","author":"T Osawa","year":"2018","unstructured":"Osawa T, Morimoto K, Sasaki Y, Matsuda S, Yamana K, Yano R, et al. The serum ferritin level is associated with the treatment responsivity for rapidly progressive interstitial lung disease with amyopathic dermatomyositis, irrespective of the anti-MDA5 antibody level. Intern Med. 2018;57(3):387\u201391.","journal-title":"Intern Med"},{"key":"863_CR58","volume":"7","author":"E Pappa","year":"2018","unstructured":"Pappa E, Gkeka M, Protogerou A, Marinos L, Loupa C, Christopoulos C. Case Report: Clinically amyopathic dermatomyositis presenting acutely with isolated facial edema. F1000Res. 2018;7:60.","journal-title":"F1000Res"},{"key":"863_CR59","doi-asserted-by":"crossref","unstructured":"Ansari G, Khan A, Mahto A, Pakozdi A. 125 A case of anti-SAE amyopathic dermatomyositis. Rheumatology (Oxford) 2019; 58 (Supp 3):iii920-iii92","DOI":"10.1093\/rheumatology\/kez108.033"},{"issue":"100896","key":"863_CR60","volume":"28","author":"H-Y Shi","year":"2019","unstructured":"Shi H-Y, Li X-R, Wei L-Q, Peng S-C. Blood purification in two patients with clinically amyopathic dermatomyositis associated with interstitial lung disease with anti-melanoma differentiation-associated gene-5 antibody (MDA-5). Respir Med Case Rep. 2019;28(100896):100896.","journal-title":"Respir Med Case Rep"},{"issue":"8","key":"863_CR61","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s10067-019-04562-w","volume":"38","author":"E Jia","year":"2019","unstructured":"Jia E, Wei J, Geng H, Qiu X, Xie J, Xiao Y, et al. Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review. Clin Rheumatol. 2019;38(8):2189\u201393.","journal-title":"Clin Rheumatol"},{"key":"863_CR62","doi-asserted-by":"crossref","unstructured":"Manudhane AP, Schrom KP, Ezaldein HH, Armile JA. Low-dose naltrexone: a unique treatment for amyopathic dermatomyositis. Dermatol. Online J. 2019;25(6):13030\/qt89b75552.","DOI":"10.5070\/D3256044451"},{"issue":"37","key":"863_CR63","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021943","volume":"99","author":"Y Ishikawa","year":"2020","unstructured":"Ishikawa Y, Kasuya T, Fujiwara M, Kita Y. Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: a case report: a case report. Medicine (Baltimore). 2020;99(37):e21943.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"863_CR64","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.4103\/jfmpc.jfmpc_106_20","volume":"9","author":"S Bandi","year":"2020","unstructured":"Bandi S, Jain V, Jaiswal AK. Amyopathic dermatomyositis with diffuse lung disease. J Fam Med Prim Care. 2020;9(6):3147\u201350.","journal-title":"J Fam Med Prim Care"},{"issue":"3","key":"863_CR65","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2169\/internalmedicine.3604-19","volume":"59","author":"M Kori","year":"2020","unstructured":"Kori M, Awano N, Inomata M, Kuse N, Tone M, Yoshimura H, et al. Anti-MDA5 antibody-positive clinically amyopathic dermatomyositis complicated by unilateral right-sided interstitial lung disease. Intern Med. 2020;59(3):401\u20138.","journal-title":"Intern Med"},{"key":"863_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.610554","volume":"7","author":"Q-C Zhang","year":"2020","unstructured":"Zhang Q-C, Liu M-Y, Chen Z-X, Chen YT, Lin C-S, Xu Q. Case report: treatment of anti-MDA5-positive amyopathic dermatomyositis accompanied by a rapidly progressive interstitial lung diseases with methylprednisolone pulse therapy combined with cyclosporine A and hydroxychloroquine. Front Med (Lausanne). 2020;7:610554.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"863_CR67","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12890-020-01335-z","volume":"20","author":"M Cao","year":"2020","unstructured":"Cao M, Zhang S, Chu D, Xiao M, Liu X, Yu L, et al. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report. BMC Pulm Med. 2020;20(1):304.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"863_CR68","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12890-020-01256-x","volume":"20","author":"ZY Li","year":"2020","unstructured":"Li ZY, Gill E, Mo F, Reyes C. Double anti-PL-7 and anti-MDA-5-positive amyopathic dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient. BMC Pulm Med. 2020;20(1):220.","journal-title":"BMC Pulm Med"},{"key":"863_CR69","doi-asserted-by":"crossref","unstructured":"Carrington AE, Tartar DM, Sivamani RK. Anti-MDA-5 negative, anti-Ku-positive clinically amyopathic dermatomyositis. Dermatol. Online J. 2021;27(4):13030\/qt1qg7x8gf.","DOI":"10.5070\/D3274053154"},{"issue":"12","key":"863_CR70","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1007\/s11606-021-07131-7","volume":"36","author":"CB Kersey","year":"2021","unstructured":"Kersey CB, Oshinsky C, Wahl ER, Newman TA. Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis: case report and literature review. J Gen Intern Med. 2021;36(12):3865\u20138.","journal-title":"J Gen Intern Med"},{"issue":"11","key":"863_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.865","volume":"9","author":"H Ishihara","year":"2021","unstructured":"Ishihara H, Kataoka K, Takei R, Yamano Y, Yokoyama T, Matsuda T, et al. Anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: a case report. Respirol Case Rep. 2021;9(11):e0865.","journal-title":"Respirol Case Rep"},{"key":"863_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.742823","volume":"8","author":"Q Gu","year":"2021","unstructured":"Gu Q, Diao M, Hu W, Huang M, Zhu Y. Case report: Extracorporeal membrane oxygenation for rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis in a post-partum woman. Front Med (Lausanne). 2021;8:742823.","journal-title":"Front Med (Lausanne)"},{"key":"863_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.625495","volume":"12","author":"C Chen","year":"2021","unstructured":"Chen C, Chen Y, Huang Q, Hu Q, Hong X. Case report: Rapidly progressive interstitial lung disease in a pregnant patient with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis. Front Immunol. 2021;12:625495.","journal-title":"Front Immunol"},{"issue":"8","key":"863_CR74","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omab061","volume":"2021","author":"M Kitamura","year":"2021","unstructured":"Kitamura M, Sugimoto H. Clinically amyopathic dermatomyositis during the COVID-19 pandemic. Oxf Med Case Rep. 2021;2021(8):omab061.","journal-title":"Oxf Med Case Rep"},{"issue":"3","key":"863_CR75","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000519104","volume":"13","author":"N Alqahtani","year":"2021","unstructured":"Alqahtani N, Aleissa M. Cutaneous features of anti-MDA-5 antibody-positive amyopathic dermatomyositis in a Sudanese patient. Case Rep Dermatol. 2021;13(3):481\u20135.","journal-title":"Case Rep Dermatol"},{"issue":"4","key":"863_CR76","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.anpedi.2020.11.029","volume":"95","author":"M Nav\u00edo Anaya","year":"2021","unstructured":"Nav\u00edo Anaya M, Monrabal Bernab\u00e9u A, Pons Morales S, Castillo Corull\u00f3n S. Dermatomiositis cl\u00ednicamente amiop\u00e1tica con afectaci\u00f3n pulmonar, enfermedad excepcional. An Pediatr Barc. 2021;95(4):282\u20133.","journal-title":"An Pediatr Barc"},{"issue":"2","key":"863_CR77","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/clinpract11020035","volume":"11","author":"H Aissaoui","year":"2021","unstructured":"Aissaoui H, Alsibai KD, Khayath N. Fast-onset diffuse interstitial lung disease in anti-MDA5 antibodies-associated amyopathic dermatomyositis. Clin Pract. 2021;11(2):235\u201340.","journal-title":"Clin Pract"},{"issue":"3","key":"863_CR78","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4103\/atm.atm_739_20","volume":"16","author":"A Mobeireek","year":"2021","unstructured":"Mobeireek A, Conca W, Mohammed S, AlObaid F, AlHajji M. Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis. Ann Thorac Med. 2021;16(3):294\u20138.","journal-title":"Ann Thorac Med"},{"issue":"16","key":"863_CR79","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.2169\/internalmedicine.6931-20","volume":"60","author":"D Kishida","year":"2021","unstructured":"Kishida D, Ushiyama S, Shimojima Y, Ueno K-I, Kurashina J-I, Shirai T, et al. Painless panniculitis upon the treatment of clinically amyopathic dermatomyositis with anti-MDA5 antibody. Intern Med. 2021;60(16):2697\u2013700.","journal-title":"Intern Med"},{"issue":"1","key":"863_CR80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12891-021-03996-1","volume":"22","author":"D-H Lim","year":"2021","unstructured":"Lim D-H, So MW, Kim YM, Ryu JH, Lee JH, Park CS, et al. Clinically amyopathic dermatomyositis presenting with isolated facial edema complicated by acute respiratory failure: a case report. BMC Musculoskelet Disord. 2021;22(1):117.","journal-title":"BMC Musculoskelet Disord"},{"issue":"101606","key":"863_CR81","volume":"36","author":"T Hiramatsu","year":"2022","unstructured":"Hiramatsu T, Murano M, Nakai S, Murakami Y, Nishimoto K, Matsushima S, et al. Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies. Respir Med Case Rep. 2022;36(101606):101606.","journal-title":"Respir Med Case Rep"},{"key":"863_CR82","doi-asserted-by":"crossref","unstructured":"Lee MA, Scott-Lang V, Raja K, Sahu S. P225 A case of PL-7-positive amyopathic dermatomyositis associated with autoimmune liver disease. Rheumatology (Oxford) 2022;61(Supplement_1): i126.","DOI":"10.1093\/rheumatology\/keac133.224"},{"key":"863_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.855408","volume":"13","author":"H Wu","year":"2022","unstructured":"Wu H, Diao L, Xue K, Zhao Q, Zhao X, Xia Q, et al. Case report: concurrence of dermatomyositis and autoimmune blistering diseases: two case reports and a literature review. Front Immunol. 2022;13:855408.","journal-title":"Front Immunol"},{"issue":"7","key":"863_CR84","volume":"15","author":"S Skrimizeas","year":"2023","unstructured":"Skrimizeas S, Dimeas IE, Dimeas G, Tzouvelekis A, Daniil Z. Anti-Ro52\/anti-nuclear matrix protein 2-positive clinically amyopathic dermatomyositis presented only with interstitial lung disease. Cureus. 2023;15(7):e42118.","journal-title":"Cureus"},{"issue":"3","key":"863_CR85","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejr.2023.03.005","volume":"45","author":"W Sulaiman","year":"2023","unstructured":"Sulaiman W, Mohd Lepatoni F, Tang JJ, Baharudin NB. Juvenile clinically amyopathic dermatomyositis (CADM): case-based review. Egypt Rheumatol. 2023;45(3):203\u20137.","journal-title":"Egypt Rheumatol"},{"issue":"12","key":"863_CR86","volume":"15","author":"A Imzil","year":"2023","unstructured":"Imzil A, Assoufi N, Mouline S, El Kharras A, Naji-Amrani H. Rapidly progressive interstitial lung disease with pneumothorax and pneumomediastinum secondary to amyopathic dermatomyositis. Cureus. 2023;15(12):e50780.","journal-title":"Cureus"},{"issue":"7","key":"863_CR87","volume":"15","author":"A Harazeen","year":"2023","unstructured":"Harazeen A, Walter B, Li X, Patel C. When a painful rash keeps recurring: a case of seronegative amyopathic dermatomyositis without neurological sequelae. Cureus. 2023;15(7):e42727.","journal-title":"Cureus"},{"issue":"1","key":"863_CR88","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2391445","volume":"35","author":"X Huang","year":"2024","unstructured":"Huang X, Zhang G, Luo S. A case of refractory anti-MDA5-positive amyopathic dermatomyositis successfully treated with upadacitinib. J Dermatol Treat. 2024;35(1):2391445.","journal-title":"J Dermatol Treat"},{"issue":"100070","key":"863_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2024.100070","volume":"24","author":"MT Ghaffar","year":"2024","unstructured":"Ghaffar MT, Warda M, Afsar M, Damodar M. A case of skin rash associated with spontaneous pneumomediastinum. Clin Med. 2024;24(100070):100070.","journal-title":"Clin Med"},{"issue":"18","key":"863_CR90","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.2169\/internalmedicine.2915-23","volume":"63","author":"M Yamazoe","year":"2024","unstructured":"Yamazoe M, Takeda K, Nagano Y, Nagano K, Kato K, Inoue T, et al. Anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressing interstitial lung disease successfully treated by initiation of combined immunosuppressive therapy plus plasma exchange and subsequently switching tacrolimus to tofacitinib. Intern Med. 2024;63(18):2571\u20138.","journal-title":"Intern Med"},{"issue":"6","key":"863_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.1403","volume":"12","author":"N Arakawa","year":"2024","unstructured":"Arakawa N, Shiota Y, Onizawa F, Miyata F, Miyoshi A, Akaba T, et al. Autoimmune pulmonary alveolar proteinosis during the treatment of nonspecific interstitial pneumonia complicated by clinically amyopathic dermatomyositis: a case report. Respirol Case Rep. 2024;12(6):e01403.","journal-title":"Respirol Case Rep"},{"issue":"2","key":"863_CR92","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1097\/MS9.0000000000001669","volume":"86","author":"AV De Jesus","year":"2024","unstructured":"De Jesus AV, De Souza JM. Clinically amyopathic dermatomyositis associated with cutaneous ulcerations: a case-based review. Ann Med Surg. 2024;86(2):1210\u20134.","journal-title":"Ann Med Surg"},{"issue":"10","key":"863_CR93","volume":"16","author":"AC Monteiro","year":"2024","unstructured":"Monteiro AC, Santana T, Tom\u00e1s AR, Negrao C, Matos C. Critical crossroads: the vital role of timely diagnosis in severe amyopathic dermatomyositis. Cureus. 2024;16(10):e70875.","journal-title":"Cureus"},{"issue":"5","key":"863_CR94","doi-asserted-by":"publisher","first-page":"823","DOI":"10.4103\/idoj.idoj_399_23","volume":"15","author":"NH Patel","year":"2024","unstructured":"Patel NH, Padhiyar JK, Patel JR, Pandya KV. Favorable response to adjuvant tofacitinib in a case of anti-melanoma differentiation-associated gene-5 antibody-positive clinically amyopathic dermatomyositis. Indian Dermatol Online J. 2024;15(5):823\u20137.","journal-title":"Indian Dermatol Online J"},{"key":"863_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1472667","volume":"15","author":"G-C Ling","year":"2024","unstructured":"Ling G-C, Su C, Guo Y-A, Qiu X, Liu J-W, Xiao M, et al. Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report. Front Pharmacol. 2024;15:1472667.","journal-title":"Front Pharmacol"},{"key":"863_CR96","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jdcr.2024.06.033","volume":"51","author":"A Sohn","year":"2024","unstructured":"Sohn A, Bouch\u00e9 N, Lewitt GM, Song EJ. Successful treatment of refractory amyopathic dermatomyositis with upadacitinib in prior JAK inhibitor failure. JAAD Case Rep. 2024;51:97\u20139.","journal-title":"JAAD Case Rep"},{"issue":"10","key":"863_CR97","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2169\/internalmedicine.2382-23","volume":"63","author":"K Saito","year":"2024","unstructured":"Saito K, Temmoku J, Sumichika Y, Yoshida S, Matsumoto H, Fujita Y, et al. Successful treatment of ultrasound-confirmed synovitis in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with corticosteroid therapy. Intern Med. 2024;63(10):1473\u20138.","journal-title":"Intern Med"},{"key":"863_CR98","doi-asserted-by":"crossref","unstructured":"Nakanishi Y, Watanabe H, Tsuyuki M, Kakumoto S, Abe M, Hamai K. New-onset anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis following COVID-19: a case report. Intern Med. 2025;(5163\u201324).","DOI":"10.2169\/internalmedicine.5163-24"},{"key":"863_CR99","doi-asserted-by":"crossref","unstructured":"Chaudhry S, Lopez K, Raghunath R, Ogunbambi O. OA20 A case of rapidly progressive interstitial lung disease in anti-Ro52-positive amyopathic dermatomyositis. Rheumatol Adv Pract. 2025;9(Supplement_1):rkaf111.019.","DOI":"10.1093\/rap\/rkaf111.019"},{"key":"863_CR100","doi-asserted-by":"crossref","unstructured":"Matusov G, Do T, Keating R, Mannor G, White A. Debilitating periorbital edema secondary to anti-SAE dermatomyositis. Ann. Intern. Med Clin Cases. 2025;4(7) sp.","DOI":"10.7326\/aimcc.2025.0236"},{"key":"863_CR101","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaf111.131","author":"MM Islam","year":"2025","unstructured":"Islam MM, Silva S, Staveley-Wadham L, Illangantilaka S. P102 Deceptive rash, deadly turn: normal creatine kinase masks a surprise life-threatening respiratory crisis\u2014a gripping case report. Rheumatol Adv Pract. 2025. https:\/\/doi.org\/10.1093\/rap\/rkaf111.131.","journal-title":"Rheumatol Adv Pract"},{"issue":"3","key":"863_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.70261","volume":"13","author":"H Prajapati","year":"2025","unstructured":"Prajapati H, Chauhan YR, Patel SY, Parmar AC, Shaikhjiwala TM. Multisystemic complications and rapid decline in anti-MDA-5-positive amyopathic dermatomyositis: a case study. Clin Case Rep. 2025;13(3):e70261.","journal-title":"Clin Case Rep"},{"key":"863_CR103","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jdcr.2025.01.047","volume":"62","author":"ME McNamara","year":"2025","unstructured":"McNamara ME, Tjahjono L. Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin. JAAD Case Rep. 2025;62:6\u20138.","journal-title":"JAAD Case Rep"},{"issue":"1","key":"863_CR104","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/archderm.138.1.23","volume":"138","author":"M Caproni","year":"2002","unstructured":"Caproni M, Cardinali C, Parodi A, Giomi B, Papini M, Vaccaro M, et al. Amyopathic dermatomyositis: a review by the Italian Group of Immunodermatology. Arch Dermatol. 2002;138(1):23\u20137.","journal-title":"Arch Dermatol"},{"issue":"6","key":"863_CR105","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jaad.2007.08.024","volume":"57","author":"RQ Klein","year":"2007","unstructured":"Klein RQ, Teal V, Taylor L, Troxel AB, Werth VP. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. J Am Acad Dermatol. 2007;57(6):937\u201343.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"863_CR106","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ad.2010.10.017","volume":"102","author":"C Ciudad-Blanco","year":"2011","unstructured":"Ciudad-Blanco C, Avil\u00e9s Izquierdo JA, Campos-Dom\u00ednguez M, Su\u00e1rez-Fern\u00e1ndez R, L\u00e1zaro Ochaita P. Dermatomyositis: assessment and follow-up of 20 patients. Actas Dermosifiliogr. 2011;102(6):448\u201355.","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"863_CR107","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10067-015-3139-z","volume":"35","author":"Y Xu","year":"2016","unstructured":"Xu Y, Yang CS, Li YJ, Liu XD, Wang JN, Zhao Q, et al. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis. Clin Rheumatol. 2016;35(1):113\u20136.","journal-title":"Clin Rheumatol"},{"key":"863_CR108","doi-asserted-by":"crossref","unstructured":"Gan Y-Z, Zhang L-H, Ma L, Sun F, Li Y-H, An Y, et al. Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis. Chin Med J (Engl). 2020;NA(6):644\u20139.","DOI":"10.1097\/CM9.0000000000000691"},{"issue":"12","key":"863_CR109","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2169\/internalmedicine.42.1253","volume":"42","author":"Y Shimojima","year":"2003","unstructured":"Shimojima Y, Ishii W, Kato T, Hoshi K, Matsuda M, Hashimoto T, et al. Intractable skin necrosis and interstitial pneumonia in amyopathic dermatomyositis, successfully treated with cyclosporin A. Intern Med. 2003;42(12):1253\u20138.","journal-title":"Intern Med"},{"issue":"6","key":"863_CR110","first-page":"492","volume":"9","author":"Y Arnson","year":"2007","unstructured":"Arnson Y, Dovrish Z, Hadari R, Amital H. Amyopathic dermatomyositis\u2014an uncommon presentation of dermatomyositis. Isr Med Assoc J. 2007;9(6):492\u20133.","journal-title":"Isr Med Assoc J"},{"key":"863_CR111","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.epsc.2016.04.009","volume":"9","author":"R Mejias","year":"2016","unstructured":"Mejias R, Schad C, Okochi S, Cheung EW, Starr AJ, Kadenhe-Chiweshe A, et al. Bridge to diagnosis: the use of extracorporeal membrane oxygenation in a child with interstitial lung disease secondary to clinically amyopathic dermatomyositis. J Pediatr Surg Case Rep. 2016;9:31\u20133.","journal-title":"J Pediatr Surg Case Rep"},{"issue":"3","key":"863_CR112","volume":"14","author":"T Ruppel","year":"2022","unstructured":"Ruppel T, Forbes Kaprive J, Heydari-Kamjani M, Kesselman MM. Anti-melanoma differentiation-associated gene 5 (anti-MDA5) dermatomyositis: a case presentation. Cureus. 2022;14(3):e23102.","journal-title":"Cureus"},{"issue":"9","key":"863_CR113","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/qjmed\/hcac148","volume":"115","author":"J Samanta","year":"2022","unstructured":"Samanta J, Naidu GSRSNK, Sood R, Nada R, Sharma A, Jain S. Calcinosis cutis with amyopathic dermatomyositis. QJM. 2022;115(9):613\u20134.","journal-title":"QJM"},{"issue":"9","key":"863_CR114","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s10067-023-06643-3","volume":"42","author":"Q Shao","year":"2023","unstructured":"Shao Q. Ulcerative rash in a patient with anti-MDA5 antibody-associated clinically amyopathic dermatomyositis. Clin Rheumatol. 2023;42(9):2515\u20136.","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00863-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-026-00863-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00863-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:16:10Z","timestamp":1785518170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-026-00863-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["863"],"URL":"https:\/\/doi.org\/10.1007\/s40744-026-00863-0","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jucier Gon\u00e7alves J\u00fanior, Jamily Izabel Alves dos Santos, and Samuel Katsuyuki Shinjo have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}